SCHEMBL14760360

SCHEMBL14760360

CCN(CC)C(=O)[C@@H]1C[C@@H]1C(N)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.58
TSHR P16473 2/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
MAPK1 P28482 1/20 0.58
HSD17B10 Q99714 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
KMT2A Q03164 1/20 0.40
GPR88 Q9GZN0 1/20 0.40
OPRD1 P41143 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL516132 0.92 CYP3A4 (0.52) CYP3A4TSHRCYP1A2CYP2D6MAPK1
SCHEMBL516778 0.78 HPGD (0.42) CYP3A4TSHRCYP1A2CYP2D6MAPK1
SCHEMBL515685 0.77 CYP3A4 (0.46) CYP3A4TSHRCYP1A2CYP2D6MAPK1
SCHEMBL515694 0.77 ALDH1A1 (0.43) CYP3A4TSHRCYP1A2CYP2D6MAPK1
SCHEMBL515952 0.77 POLB (0.43) CYP3A4TSHRCYP1A2CYP2D6MAPK1
SCHEMBL516110 0.77 OPRM1 (0.43) OPRD1
SCHEMBL515948 0.77 SLC6A2 (0.41) CYP3A4TSHRCYP1A2CYP2D6MAPK1
SCHEMBL515667 0.75 CYP1A2 (0.47) CYP3A4TSHRCYP1A2CYP2D6MAPK1
SCHEMBL516182 0.75 L3MBTL1 (0.43) CYP3A4TSHRCYP1A2CYP2D6MAPK1
SCHEMBL516137 0.74 GPR88 (0.39) CYP3A4TSHRCYP1A2CYP2D6MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455550-B2 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products PIERRE FABRE MEDICAMENT (FR) 2013-06-04 US disclosed
EP-2414323-B1 DERIVATIVES OF AMINOCYCLOBUTANE OR AMINOCYCLOBUTENE, THEIR METHOD OF PREPARATION AND THEIR USE AS MEDICAL PRODUCTS PF MEDICAMENT (FR) 2013-03-13 EP disclosed